192 related articles for article (PubMed ID: 17918192)
1. Loss of the eukaryotic initiation factor 3f in pancreatic cancer.
Doldan A; Chandramouli A; Shanas R; Bhattacharyya A; Cunningham JT; Nelson MA; Shi J
Mol Carcinog; 2008 Mar; 47(3):235-44. PubMed ID: 17918192
[TBL] [Abstract][Full Text] [Related]
2. Loss of the eukaryotic initiation factor 3f in melanoma.
Doldan A; Chandramouli A; Shanas R; Bhattacharyya A; Leong SP; Nelson MA; Shi J
Mol Carcinog; 2008 Oct; 47(10):806-13. PubMed ID: 18381585
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
Shi J; Kahle A; Hershey JW; Honchak BM; Warneke JA; Leong SP; Nelson MA
Oncogene; 2006 Aug; 25(35):4923-36. PubMed ID: 16532022
[TBL] [Abstract][Full Text] [Related]
4. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.
Esteves P; Dard L; Brillac A; Hubert C; Sarlak S; Rousseau B; Dumon E; Izotte J; Bonneu M; Lacombe D; Dupuy JW; Amoedo N; Rossignol R
Oncogene; 2020 Jan; 39(3):617-636. PubMed ID: 31527668
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis.
Shi J; Hershey JW; Nelson MA
FEBS Lett; 2009 Mar; 583(6):971-7. PubMed ID: 19245811
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I-III gastric cancer.
Li G; Wang N; Sun C; Li B
World J Surg Oncol; 2014 Mar; 12():72. PubMed ID: 24678890
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
Cuesta R; Berman AY; Alayev A; Holz MK
J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation.
Wen F; Zhou R; Shen A; Choi A; Uribe D; Shi J
PLoS One; 2012; 7(3):e34194. PubMed ID: 22457825
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
10. eIF3f depletion impedes mouse embryonic development, reduces adult skeletal muscle mass and amplifies muscle loss during disuse.
Docquier A; Pavlin L; Raibon A; Bertrand-Gaday C; Sar C; Leibovitch S; Candau R; Bernardi H
J Physiol; 2019 Jun; 597(12):3107-3131. PubMed ID: 31026345
[TBL] [Abstract][Full Text] [Related]
11. Expression of eukaryotic initiation factor 3f is associated with prognosis in gastric carcinomas.
Cheng Y; Jia C; Li G; Li H
Oncol Res Treat; 2014; 37(4):198-202. PubMed ID: 24732644
[TBL] [Abstract][Full Text] [Related]
12. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
Lee JY; Kim HJ; Rho SB; Lee SH
Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.
Cheng Y; Zhou J; Li H
Clin Transl Sci; 2015 Aug; 8(4):320-5. PubMed ID: 25684180
[TBL] [Abstract][Full Text] [Related]
14. The eukaryotic translation initiation factor 3f (eIF3f) interacts physically with the alpha 1B-adrenergic receptor and stimulates adrenoceptor activity.
Gutiérrez-Fernández MJ; Higareda-Mendoza AE; Gómez-Correa CA; Pardo-Galván MA
BMC Biochem; 2015 Oct; 16():25. PubMed ID: 26497985
[TBL] [Abstract][Full Text] [Related]
15. The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation.
Moretti J; Chastagner P; Gastaldello S; Heuss SF; Dirac AM; Bernards R; Masucci MG; Israël A; Brou C
PLoS Biol; 2010 Nov; 8(11):e1000545. PubMed ID: 21124883
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers.
Takahashi S; Suzuki S; Inaguma S; Ikeda Y; Cho YM; Nishiyama N; Fujita T; Inoue T; Hioki T; Sugimura Y; Ushijima T; Shirai T
Prostate; 2002 Feb; 50(3):154-61. PubMed ID: 11813207
[TBL] [Abstract][Full Text] [Related]
18. The translational factor eIF3f: the ambivalent eIF3 subunit.
Marchione R; Leibovitch SA; Lenormand JL
Cell Mol Life Sci; 2013 Oct; 70(19):3603-16. PubMed ID: 23354061
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.
Harada T; Chelala C; Bhakta V; Chaplin T; Caulee K; Baril P; Young BD; Lemoine NR
Oncogene; 2008 Mar; 27(13):1951-60. PubMed ID: 17952125
[TBL] [Abstract][Full Text] [Related]
20. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
